Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 111

Sort by

Sort Order Select

Journal Articles

The Histone Acetyltransferase MOZ (KAT6A) Is a Molecular Dependency and Therapeutic Target in NUP98 -Rearranged Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 825.

https://doi.org/10.1182/blood-2024-210529

Published: 2024

Journal Articles

RNA Modifications on Long Non-Coding RNAs in Multiple Myeloma

Catheryn Bolick, Prasanth Thunuguntla, Dakota Colbert, Steve Daly, Yash Rajana, Jaiyana King, Matthew Mueller, Dhanusha Duraiyan, Benjamin A Garcia, John F. DiPersio, Jessica Silva-Fisher

Blood (2024) 144 (Supplement 1): 6836.

https://doi.org/10.1182/blood-2024-207137

Published: 2024

Journal Articles

De Novo DLBCL with Concurrent Monoclonal B-Cell Lymphocytosis CLL-Type Exhibits Biological Characteristics Similar to Richter Syndrome

Fernando Martín Moro, Miguel Alcoceba, Samuel Romero, Juan Marquet, David Alonso Castronuño, Beatriz Astibia Mahillo, Rafael Andreu, Rocío Pérez Alonso, Cristina De Ramón, Irene Solano, Eulalia Rodríguez Martín, Miguel Piris-Villaespesa, Ernesto Roldán Santiago, Jose A. Garcia-Marco, Dolores Subirá, Almudena Navarro Bailon, José Antonio Garcia Vela, Mónica García-Cosío, Javier López

Blood (2024) 144 (Supplement 1): 6267.

https://doi.org/10.1182/blood-2024-211699

Published: 2024

Journal Articles

Large Deletion in the Factor VIII Gene Is a Predictor of Immune Tolerance Induction Failure in People with Severe and Moderately-Severe Hemophilia a and High-Responding Inhibitors

Blood (2023) 142 (Supplement 1): 1245.

https://doi.org/10.1182/blood-2023-186074

Published: 2023

Journal Articles

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Jonathan Avery, Kylee L Martens, Daniel Nguyen, Ryan Basom, Stephanie Lee, David A. Garcia, Cristhiam Mauricio Rojas Hernandez, Ang Li

Blood (2022) 140 (Supplement 1): 7860–7861.

https://doi.org/10.1182/blood-2022-165426

Published: 2022

Journal Articles

Proteotranscriptomic Strategy to Discover Acute Myeloid Leukemia Immunotherapy Targets

Lusha Cao, Yang Xu, Tina Glisovic-Aplenc, Kevin Nestler, Saar Gill, Kathrin M. Bernt, Benjamin A Garcia, Hossein Fazelinia, Lingyu Guan, Yi Xing, Richard Aplenc

Blood (2022) 140 (Supplement 1): 3425–3426.

https://doi.org/10.1182/blood-2022-167378

Published: 2022

Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Blood (2022) 140 (Supplement 1): 9908–9910.

https://doi.org/10.1182/blood-2022-162186

Published: 2022

Journal Articles

Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms Independent of FLT3-Mutation Status: Final Results of a Phase 1/2 Study

Anna B. Halpern, Eduardo P Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M. Percival, Ryan D. Cassaday, Vivian G. Oehler, Pamela S. Becker, Jacob S. Appelbaum, Janis L. Abkowitz, Johnnie J. Orozco, Sioban B. Keel, Paul C. Hendrie, Bart L. Scott, Cristina Ghiuzeli, Roland B. Walter, Elihu H. Estey

Blood (2022) 140 (Supplement 1): 8999–9001.

https://doi.org/10.1182/blood-2022-159882

Published: 2022

Journal Articles

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Sarah B May, Jennifer La, Emily Milner, Nimrah Riaz, Christopher I Amos, David A. Garcia, Marc Carrier, Neil Zakai, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, Nathanael Fillmore, Ang Li

Blood (2022) 140 (Supplement 1): 7968–7970.

https://doi.org/10.1182/blood-2022-162658

Published: 2022

Journal Articles

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Ang Li, Jennifer La, Sarah B May, Danielle Guffey, Wilson L Da Costa, Jr., Christopher I Amos, Emily Milner, Raka Bandyo, Carolina Granada, Nimrah Riaz, Nhan V Do, Mary Brophy, Vipul Chitalia, J. Michael Gaziano, David A. Garcia, Marc Carrier, Christopher R. Flowers, Neil Zakai, Nathanael Fillmore

Blood (2022) 140 (Supplement 1): 5637–5639.

https://doi.org/10.1182/blood-2022-160017

Published: 2022

Journal Articles

Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review

Kanak Parmar, Shivam Singh, Lukman Tijani, David A. Garcia

Blood (2022) 140 (Supplement 1): 5608–5609.

https://doi.org/10.1182/blood-2022-164546

Published: 2022

Journal Articles

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, David Allsup, Alejandro Alonso Cabrero, Martin Andres, Monica Baile Gonzales, Antonella Capasso, Rosa Collado, Raul Cordoba, Carolina Cuéllar-García, Juan Gonzalo Correa, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Alberto Lopez-Garcia, Jose A. Garcia-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Maria Gomes da Silva, Odit Gutwein, Yervand Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Оlga B. Kalashnikova, Elżbieta Kalicińska, Arnon P. Kater, Sabina Kersting, Maya Koren-Michowitz, Jorge Labrador Gomez, Deepesh Lad, Luca Laurenti, Alberto Fresa, Mark-David Levin, Carlota Mayor Bastida, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Biljana Mihaljevic, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Raquel Nunes, Jacopo Olivieri, Miguel Arturo Pavlovsky, Inga S. Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Gianluigi Reda, Gian Matteo Rigolin, Amit Shrestha, Martin Šimkovič, Svetlana Smirnova, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Doreen Te Raa, Kristina Tomic, Sanne Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Marzia Varettoni, Andrea Visentin, Candida Vitale, Vojin Vukovic, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yanez San Segundo, Mohamed A Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Marc Carrier, Paolo Ghia, Kostas Stamatopoulos

Blood (2022) 140 (Supplement 1): 2772–2775.

https://doi.org/10.1182/blood-2022-169909

Published: 2022

Journal Articles

Thrombophilia Testing Patterns, Result Interpretation, and Clinical Outcomes in a Retrospective Cohort of Patients with Retinal Vascular Occlusion

Jonathan Zawadzki, Debbie Jiang, David A. Garcia, Daniel E. Sabath

Blood (2022) 140 (Supplement 1): 5007–5008.

https://doi.org/10.1182/blood-2022-168035

Published: 2022

Journal Articles

Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study

Andrea Visentin, Lydia Scarfò, Thomas Chatzikonstantinou, Anargyros Kapetanakis, Christos Demosthenous, Georgios Karakatsoulis, Martin Andres, Darko Antic, David Allsup, Mónica Baile, Dominique Bron, Antonella Capasso, Mark Catherwood, Rosa Collado, Raul Cordoba, Carolina Cuéllar-García, Julio Delgado, Maria Dimou, Michael Doubek, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Maria Efstathopoulou, El-Ashwah Shimaa, Alicia Enrico, Lucia Farina, Angela Ferrari, Myriam Foglietta, Moritz Furstenau, Jose A. Garcia-Marco, Massimo Gentile, Eva Gimeno, Gomes da Silva Maria, Odit Gutwein, Yervand Hakobyan, Yair Herishanu, jose Angel Hernandez, Tobias Herold, Sunil Iyengar, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Olga Kalashnikova, Elzbieta Kalicinska, Arnon P. Kater, Sabina Kersting, Jorge Labrador, Deepesh Lad, Luca Laurenti, Mark-David Levin, Enrico Lista, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet Palomanes, Mattias Mattsson, Francesca Romana Mauro, Carlota Mayor-Bastida, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Ivana Milosevic, Fatima Miras Calvo, Carsten Utoft Niemann, Jacopo Olivieri, Lorella Orsucci, Maria Papaioannou, Miguel Arturo Pavlovsky, Inga S. Piskunova, Barbara Pocali, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Doreen te Raa, Gianluigi Reda, Gian Matteo Rigolin, Rosa Ruchlemer, Amit Shrestha, Martin Šimkovič, Martin Špaček, Paolo Sportoletti, Oana Stanca Ciocan, Tamar Tadmor, Elisabeth Vandenberghe, Marzia Varettoni, Candida Vitale, Ellen Van Der Spek, Michel Van Gelder, Ewa Wasik-Szczepanek, Lucrecia Yáñez, Mohamed A Yassin, Marta Coscia, Barbara Eichhorst, Alessandro Rambaldi, Niki Stavroyianni, Livio Trentin, Kostas Stamatopoulos, Paolo Ghia

Blood (2022) 140 (Supplement 1): 2333–2337.

https://doi.org/10.1182/blood-2022-163259

Published: 2022

Journal Articles

Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant

Ang Li, Kylee L Martens, Daniel Nguyen, Gabriela Rondon, Christopher I Amos, Stephanie J. Lee, Ryan Basom, Chris Davis, David A. Garcia, Richard E. Champlin, Elizabeth J. Shpall, Cristhiam Mauricio Rojas Hernandez, Partow Kebriaei

Blood (2021) 138 (Supplement 1): 750.

https://doi.org/10.1182/blood-2021-148234

Published: 2021

Journal Articles

FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation

Pamela J. Sung, Simone Sidoli, Simone S. Riedel, Katarzyna Kulej, Hongbo Xie, Bryan Manning, Daniel Tsai, Gerald Wertheim, Benjamin A. Garcia, Sara E. Meyer, Kathrin M. Bernt, Martin P. Carroll

Blood (2021) 138 (Supplement 1): 785.

https://doi.org/10.1182/blood-2021-147313

Published: 2021

Journal Articles

Reduced-Intensity Therapy with Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Yields Durable Remissions in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Final Results of a Phase II Trial

Ryan D. Cassaday, Kelsey-Leigh A. Garcia, Olga Sala-Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary-Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerry P. Radich, Lorinda A. Soma, Elihu H. Estey

Blood (2021) 138 (Supplement 1): 4397.

https://doi.org/10.1182/blood-2021-145648

Published: 2021

Journal Articles

Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer

Wilson L Da Costa, Jr., Danielle Guffey, Raka Bandyo, Courtney D Wallace, Carolina Granada, Romil D Patel, Margaret Fitzgerald, Elizabeth Y. Chiao, David A. Garcia, Marc Carrier, Christopher I Amos, Ang Li

Blood (2021) 138 (Supplement 1): 176.

https://doi.org/10.1182/blood-2021-149221

Published: 2021

Journal Articles

Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System

Ang Li, Wilson L Da Costa, Jr., Danielle Guffey, Raka Bandyo, Courtney D Wallace, Carolina Granada, Romil Patel, Margaret Fitzgerald, Elizabeth Y. Chiao, David A. Garcia, Christopher I Amos, Marc Carrier

Blood (2021) 138 (Supplement 1): 833.

https://doi.org/10.1182/blood-2021-147390

Published: 2021

Journal Articles

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Blood (2021) 138 (Supplement 1): 1561.

https://doi.org/10.1182/blood-2021-147685

Published: 2021

NARROW

The Histone Acetyltransferase MOZ (KAT6A) Is a Molecular Dependency and Therapeutic Target in NUP98 -Rearranged Acute Myeloid Leukemia

RNA Modifications on Long Non-Coding RNAs in Multiple Myeloma

De Novo DLBCL with Concurrent Monoclonal B-Cell Lymphocytosis CLL-Type Exhibits Biological Characteristics Similar to Richter Syndrome

Large Deletion in the Factor VIII Gene Is a Predictor of Immune Tolerance Induction Failure in People with Severe and Moderately-Severe Hemophilia a and High-Responding Inhibitors

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Proteotranscriptomic Strategy to Discover Acute Myeloid Leukemia Immunotherapy Targets

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real-World Setting in Spain: An Update of the Venares Study

Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms Independent of FLT3-Mutation Status: Final Results of a Phase 1/2 Study

Venous Thromboembolism Risk in Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Vs. Chemotherapy

Derivation and External Validation of Clinical Risk Assessment Model for Cancer Associated Thrombosis in Two Unique U.S. Healthcare Systems

Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review

Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

Thrombophilia Testing Patterns, Result Interpretation, and Clinical Outcomes in a Retrospective Cohort of Patients with Retinal Vascular Occlusion

Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study

Internal and External Validation of the High-2-Low Model: A Predictive Score for Venous Thromboembolism after Allogeneic Transplant

FLT3 Inhibition Downregulates EZH2 in AML and Promotes Myeloid Differentiation

Reduced-Intensity Therapy with Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) Yields Durable Remissions in Adults with Newly-Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL): Final Results of a Phase II Trial

Impact of Race/Ethnicity on Cancer Associated Thrombosis Among Underserved Patients with Cancer

Optimizing Cancer Associated Thrombosis (CAT) Risk Assessment Model at a Safety-Net Healthcare System

Efficacy and Safety of Treatment Venetoclax Monotherapy or Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in the Real -World Setting in Spain: The Venares Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only